Clinical trial

Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function

NCT02304081

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-01-01

PhasePHASE4

Study timeline

Study start (unknown)2015-01-01Date precision: month

Registry last updated2018-06-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2 Diabetes Mellitusunresolved

Interventions

SaxagliptinDRUG · verified · RxNorm: saxagliptin

Placebo for SaxagliptinDRUG

Sponsors & collaborators

Prof. Dr. Thomas Forstlead sponsor

Mapped research locations

MainzGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02304081 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.